Seed funding recipients: Round 1
The successful projects are:
- Structure-based development of novel anti-inflammatory drugs targeting C-reactive protein, led by Professor Karlheinz Peter (Baker) with staff from the Department of Biochemistry and Molecular Biology, and Bio 21 Molecular Science and Biotechnology Institute
- Atrial remodelling and risk of arrhythmias in endurance athletes, led by Professor Andre La Gerche (Baker), with staff from the Department of Clinical Pathology and Department of Medicine and Radiology
- CAPLA trial: Catheter Ablation for persistent atrial fibrillation: a multicentre randomised trial of Pulmonary vein isolation (PVI) vs PVI with posterior Left Atrial wall isolation (PWI), led by Professor Peter Kistler (Baker), with staff from the Department of Medicine and Radiology
- Risk of heart failure in women following preeclampsia: is prevention possible?, led by Associate Professor Natalie Hannan (Department of Obstetrics and Gynaecology) with staff from the Baker and Department of Medicine and Radiology.
These projects will further strengthen the University’s partnership with the Baker Institute and will enable research groups to refine their program of work before progressing to external grant funding opportunities in the future.